Lanean...

Management of arthralgias associated with aromatase inhibitor therapy

For the upfront adjuvant therapy of postmenopausal estrogen receptor–positive breast cancer, the third-generation aromatase inhibitors (ais) have shown a more favourable overall risk–benefit profile than has tamoxifen. Benefits of the ais include less frequent gynecologic, cerebrovascular, and throm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Thorne, C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Multimed Inc. 2007
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2140182/
https://ncbi.nlm.nih.gov/pubmed/18087604
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!